scholarly journals A Phase I, Open-Label Study of Siltuximab, an Anti–IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease

2013 ◽  
Vol 19 (13) ◽  
pp. 3659-3670 ◽  
Author(s):  
Razelle Kurzrock ◽  
Peter M. Voorhees ◽  
Corey Casper ◽  
Richard R. Furman ◽  
Luis Fayad ◽  
...  
Keyword(s):  
Multiple Myeloma ◽  
Monoclonal Antibody ◽  
Phase I ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Castleman Disease ◽  
Open Label ◽  
Open Label Study ◽  
Label Study ◽  
Non Hodgkin Lymphoma

A phase I trial of ublituximab (TG-1101), a novel glycoengineered anti-CD20 monoclonal antibody (mAb) in B-cell non-Hodgkin lymphoma patients with prior exposure to rituximab.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 8524-8524 ◽  
Author(s):  
Owen A. O'Connor ◽  
Changchun Deng ◽  
Jennifer Effie Amengual ◽  
Mazen Y. Khalil ◽  
Marshall T. Schreeder ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Phase I Trial ◽  
Prior Exposure ◽  
Non Hodgkin Lymphoma ◽  
Anti Cd20

scholarly journals Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma

2009 ◽  
Vol 15 (20) ◽  
pp. 6446-6453 ◽  
Author(s):  
Stephen M. Ansell ◽  
Sara A. Hurvitz ◽  
Patricia A. Koenig ◽  
Betsy R. LaPlant ◽  
Brian F. Kabat ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Phase I ◽  
B Cell ◽  
Hodgkin Lymphoma ◽  
Phase I Study ◽  
Non Hodgkin Lymphoma

scholarly journals Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma

2013 ◽  
Vol 164 (2) ◽  
pp. 258-265 ◽  
Author(s):  
Michelle Fanale ◽  
Sarit Assouline ◽  
John Kuruvilla ◽  
Philippe Solal-Céligny ◽  
Dae S. Heo ◽  
...  
Keyword(s):  
Monoclonal Antibody ◽  
Hodgkin Lymphoma ◽  
Adult Patients ◽  
Open Label ◽  
Open Label Study ◽  
Label Study
Sign in / Sign up

Export Citation Format

Share Document